Click for best price
Biological Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 291940 million
|
Forecast Market size by 2029 |
US$ 495400 million
|
| Growth Rate |
CAGR of 7.8% |
Number of Pages |
71 Pages |
The global Biological Drugs market was valued at US$ 291940 million in 2022 and is projected to reach US$ 495400 million by 2029, at a CAGR of 7.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Biological Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Biological Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Biological Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
This report aims to provide a comprehensive presentation of the global market for Biological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Drugs. This report contains market size and forecasts of Biological Drugs in global, including the following market information:
- Global Biological Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global Biological Drugs Market Sales, 2018-2023, 2024-2030, (Units)
- Global top five Biological Drugs companies in 2022 (%)
The world biological drugs market is predicted to gain momentum with rising prevalence of chronic diseases such as cancer and diabetes across the globe. Demand for biological drugs could swell with the expansion of geriatric population at the global level. Currently growing inclination toward adoption of personalized medicines and strong research and development efforts taken to introduce new and powerful biological drugs are foretold to set the tone for a significant rise in demand.
We surveyed the Biological Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biological Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Units)
Global Biological Drugs Market Segment Percentages, by Type, 2022 (%)
- Therapeutic Protein
- Monoclonal Antibody
- Vaccine
- Others
Global Biological Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Units)
Global Biological Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Biological Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Units)
Global Biological Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biological Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Biological Drugs revenues share in global market, 2022 (%)
- Key companies Biological Drugs sales in global market, 2018-2023 (Estimated), (Units)
- Key companies Biological Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol-Myers Squibb
- Eli Lilly
- Takeda
- Pfizer
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck
- Abbott Laboratories
- Baxter
- Novartis
- Biogen
- GlaxoSmithKline
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biological Drugs, market overview.
Chapter 2: Global Biological Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Biological Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biological Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biological Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biological Drugs Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 291940 million
|
| Forecast Market size by 2029 |
US$ 495400 million
|
| Growth Rate |
CAGR of 7.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biological Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biological Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biological Drugs Overall Market Size
2.1 Global Biological Drugs Market Size: 2022 VS 2030
2.2 Global Biological Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Biological Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Biological Drugs Players in Global Market
3.2 Top Global Biological Drugs Companies Ranked by Revenue
3.3 Global Biological Drugs Revenue by Companies
3.4 Global Biological Drugs Sales by Companies
3.5 Global Biological Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biological Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biological Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biological Drugs Players in Global Market
3.8.1 List of Global Tier 1 Biological Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Biological Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biological Drugs Market Size Markets, 2022 & 2030
4.1.2 Therapeutic Protein
4.1.3 Monoclonal Antibody
4.1.4 Vaccine
4.1.5 Others
4.2 By Type - Global Biological Drugs Revenue & Forecasts
4.2.1 By Type - Global Biological Drugs Revenue, 2018-2023
4.2.2 By Type - Global Biological Drugs Revenue, 2024-2030
4.2.3 By Type - Global Biological Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Biological Drugs Sales & Forecasts
4.3.1 By Type - Global Biological Drugs Sales, 2018-2023
4.3.2 By Type - Global Biological Drugs Sales, 2024-2030
4.3.3 By Type - Global Biological Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Biological Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biological Drugs Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Others
5.2 By Application - Global Biological Drugs Revenue & Forecasts
5.2.1 By Application - Global Biological Drugs Revenue, 2018-2023
5.2.2 By Application - Global Biological Drugs Revenue, 2024-2030
5.2.3 By Application - Global Biological Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Biological Drugs Sales & Forecasts
5.3.1 By Application - Global Biological Drugs Sales, 2018-2023
5.3.2 By Application - Global Biological Drugs Sales, 2024-2030
5.3.3 By Application - Global Biological Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Biological Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Biological Drugs Market Size, 2022 & 2030
6.2 By Region - Global Biological Drugs Revenue & Forecasts
6.2.1 By Region - Global Biological Drugs Revenue, 2018-2023
6.2.2 By Region - Global Biological Drugs Revenue, 2024-2030
6.2.3 By Region - Global Biological Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Biological Drugs Sales & Forecasts
6.3.1 By Region - Global Biological Drugs Sales, 2018-2023
6.3.2 By Region - Global Biological Drugs Sales, 2024-2030
6.3.3 By Region - Global Biological Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Biological Drugs Revenue, 2018-2030
6.4.2 By Country - North America Biological Drugs Sales, 2018-2030
6.4.3 US Biological Drugs Market Size, 2018-2030
6.4.4 Canada Biological Drugs Market Size, 2018-2030
6.4.5 Mexico Biological Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Biological Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Biological Drugs Sales, 2018-2030
6.5.3 Germany Biological Drugs Market Size, 2018-2030
6.5.4 France Biological Drugs Market Size, 2018-2030
6.5.5 U.K. Biological Drugs Market Size, 2018-2030
6.5.6 Italy Biological Drugs Market Size, 2018-2030
6.5.7 Russia Biological Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Biological Drugs Market Size, 2018-2030
6.5.9 Benelux Biological Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Biological Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Biological Drugs Sales, 2018-2030
6.6.3 China Biological Drugs Market Size, 2018-2030
6.6.4 Japan Biological Drugs Market Size, 2018-2030
6.6.5 South Korea Biological Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Biological Drugs Market Size, 2018-2030
6.6.7 India Biological Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Biological Drugs Revenue, 2018-2030
6.7.2 By Country - South America Biological Drugs Sales, 2018-2030
6.7.3 Brazil Biological Drugs Market Size, 2018-2030
6.7.4 Argentina Biological Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biological Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Biological Drugs Sales, 2018-2030
6.8.3 Turkey Biological Drugs Market Size, 2018-2030
6.8.4 Israel Biological Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Biological Drugs Market Size, 2018-2030
6.8.6 UAE Biological Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Biological Drugs Major Product Offerings
7.1.4 Bristol-Myers Squibb Biological Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Biological Drugs Major Product Offerings
7.2.4 Eli Lilly Biological Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Takeda
7.3.1 Takeda Company Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Biological Drugs Major Product Offerings
7.3.4 Takeda Biological Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Takeda Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Biological Drugs Major Product Offerings
7.4.4 Pfizer Biological Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Biological Drugs Major Product Offerings
7.5.4 Amgen Biological Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Amgen Key News & Latest Developments
7.6 F. Hoffmann-La Roche
7.6.1 F. Hoffmann-La Roche Company Summary
7.6.2 F. Hoffmann-La Roche Business Overview
7.6.3 F. Hoffmann-La Roche Biological Drugs Major Product Offerings
7.6.4 F. Hoffmann-La Roche Biological Drugs Sales and Revenue in Global (2018-2023)
7.6.5 F. Hoffmann-La Roche Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Biological Drugs Major Product Offerings
7.7.4 Johnson & Johnson Biological Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Biological Drugs Major Product Offerings
7.8.4 Merck Biological Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Company Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Biological Drugs Major Product Offerings
7.9.4 Abbott Laboratories Biological Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Abbott Laboratories Key News & Latest Developments
7.10 Baxter
7.10.1 Baxter Company Summary
7.10.2 Baxter Business Overview
7.10.3 Baxter Biological Drugs Major Product Offerings
7.10.4 Baxter Biological Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Baxter Key News & Latest Developments
7.11 Novartis
7.11.1 Novartis Company Summary
7.11.2 Novartis Biological Drugs Business Overview
7.11.3 Novartis Biological Drugs Major Product Offerings
7.11.4 Novartis Biological Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Novartis Key News & Latest Developments
7.12 Biogen
7.12.1 Biogen Company Summary
7.12.2 Biogen Biological Drugs Business Overview
7.12.3 Biogen Biological Drugs Major Product Offerings
7.12.4 Biogen Biological Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Biogen Key News & Latest Developments
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Company Summary
7.13.2 GlaxoSmithKline Biological Drugs Business Overview
7.13.3 GlaxoSmithKline Biological Drugs Major Product Offerings
7.13.4 GlaxoSmithKline Biological Drugs Sales and Revenue in Global (2018-2023)
7.13.5 GlaxoSmithKline Key News & Latest Developments
8 Global Biological Drugs Production Capacity, Analysis
8.1 Global Biological Drugs Production Capacity, 2018-2030
8.2 Biological Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Biological Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biological Drugs Supply Chain Analysis
10.1 Biological Drugs Industry Value Chain
10.2 Biological Drugs Upstream Market
10.3 Biological Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biological Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biological Drugs in Global Market
Table 2. Top Biological Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biological Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biological Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Biological Drugs Sales by Companies, (Units), 2018-2023
Table 6. Global Biological Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biological Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Biological Drugs Product Type
Table 9. List of Global Tier 1 Biological Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biological Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biological Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Biological Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biological Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Biological Drugs Sales (Units), 2018-2023
Table 15. By Type - Global Biological Drugs Sales (Units), 2024-2030
Table 16. By Application ? Global Biological Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Biological Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biological Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Biological Drugs Sales (Units), 2018-2023
Table 20. By Application - Global Biological Drugs Sales (Units), 2024-2030
Table 21. By Region ? Global Biological Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Biological Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biological Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Biological Drugs Sales (Units), 2018-2023
Table 25. By Region - Global Biological Drugs Sales (Units), 2024-2030
Table 26. By Country - North America Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biological Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Biological Drugs Sales, (Units), 2018-2023
Table 29. By Country - North America Biological Drugs Sales, (Units), 2024-2030
Table 30. By Country - Europe Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biological Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Biological Drugs Sales, (Units), 2018-2023
Table 33. By Country - Europe Biological Drugs Sales, (Units), 2024-2030
Table 34. By Region - Asia Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biological Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Biological Drugs Sales, (Units), 2018-2023
Table 37. By Region - Asia Biological Drugs Sales, (Units), 2024-2030
Table 38. By Country - South America Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biological Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Biological Drugs Sales, (Units), 2018-2023
Table 41. By Country - South America Biological Drugs Sales, (Units), 2024-2030
Table 42. By Country - Middle East & Africa Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biological Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Biological Drugs Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Biological Drugs Sales, (Units), 2024-2030
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb Biological Drugs Product Offerings
Table 48. Bristol-Myers Squibb Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. Eli Lilly Company Summary
Table 51. Eli Lilly Biological Drugs Product Offerings
Table 52. Eli Lilly Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Eli Lilly Key News & Latest Developments
Table 54. Takeda Company Summary
Table 55. Takeda Biological Drugs Product Offerings
Table 56. Takeda Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Takeda Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Biological Drugs Product Offerings
Table 60. Pfizer Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Amgen Company Summary
Table 63. Amgen Biological Drugs Product Offerings
Table 64. Amgen Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Amgen Key News & Latest Developments
Table 66. F. Hoffmann-La Roche Company Summary
Table 67. F. Hoffmann-La Roche Biological Drugs Product Offerings
Table 68. F. Hoffmann-La Roche Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. F. Hoffmann-La Roche Key News & Latest Developments
Table 70. Johnson & Johnson Company Summary
Table 71. Johnson & Johnson Biological Drugs Product Offerings
Table 72. Johnson & Johnson Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Johnson & Johnson Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Biological Drugs Product Offerings
Table 76. Merck Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. Abbott Laboratories Company Summary
Table 79. Abbott Laboratories Biological Drugs Product Offerings
Table 80. Abbott Laboratories Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Abbott Laboratories Key News & Latest Developments
Table 82. Baxter Company Summary
Table 83. Baxter Biological Drugs Product Offerings
Table 84. Baxter Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Baxter Key News & Latest Developments
Table 86. Novartis Company Summary
Table 87. Novartis Biological Drugs Product Offerings
Table 88. Novartis Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Novartis Key News & Latest Developments
Table 90. Biogen Company Summary
Table 91. Biogen Biological Drugs Product Offerings
Table 92. Biogen Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Biogen Key News & Latest Developments
Table 94. GlaxoSmithKline Company Summary
Table 95. GlaxoSmithKline Biological Drugs Product Offerings
Table 96. GlaxoSmithKline Biological Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. GlaxoSmithKline Key News & Latest Developments
Table 98. Biological Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 99. Global Biological Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Biological Drugs Production by Region, 2018-2023 (Units)
Table 101. Global Biological Drugs Production by Region, 2024-2030 (Units)
Table 102. Biological Drugs Market Opportunities & Trends in Global Market
Table 103. Biological Drugs Market Drivers in Global Market
Table 104. Biological Drugs Market Restraints in Global Market
Table 105. Biological Drugs Raw Materials
Table 106. Biological Drugs Raw Materials Suppliers in Global Market
Table 107. Typical Biological Drugs Downstream
Table 108. Biological Drugs Downstream Clients in Global Market
Table 109. Biological Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biological Drugs Segment by Type in 2022
Figure 2. Biological Drugs Segment by Application in 2022
Figure 3. Global Biological Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biological Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Biological Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Biological Drugs Sales in Global Market: 2018-2030 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Biological Drugs Revenue in 2022
Figure 9. By Type - Global Biological Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Biological Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Biological Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Biological Drugs Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Biological Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Biological Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Biological Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Biological Drugs Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Biological Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Biological Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Biological Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Biological Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Biological Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Biological Drugs Sales Market Share, 2018-2030
Figure 23. US Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Biological Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Biological Drugs Sales Market Share, 2018-2030
Figure 28. Germany Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Biological Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Biological Drugs Sales Market Share, 2018-2030
Figure 37. China Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Biological Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Biological Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Biological Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Biological Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Biological Drugs Production Capacity (Units), 2018-2030
Figure 53. The Percentage of Production Biological Drugs by Region, 2022 VS 2030
Figure 54. Biological Drugs Industry Value Chain
Figure 55. Marketing Channels
